Similar risk of kidney failure among patients with blinding diseases who receive ranibizumab, aflibercept, and bevacizumab: An Observational Health Data Sciences and Informatics network study

Contact Us

Thank you for your interest in the Johns Hopkins School of Medicine Biomedical Informatics & Data Science Programs. Please complete the form below to receive information about our degree offerings.

All fields marked with an asterisk (*) are required.